A phase Ib study of NUC-3373 in combination with standard therapies in advanced/metastatic colorectal cancer (NuTide:302).Andrew L. Coveler, T.R. Jeffry Evans, Michelle Myers et al.|Journal of Clinical Oncology|2021Cited by 6
Abstract CT140: NUC-3373, a targeted inhibitor of thymidylate synthase, in patients with advanced colorectal cancerFarasat Kazmi, TR Jeffry Evans, Jordan Berlin et al.|Cancer Research|2021Cited by 2
464P Pharmacokinetic analysis of NUC-3373 with and without leucovorin in patients with previously treated metastatic colorectal cancer (NuTide:302 study)Janet Graham, Jonathan J. Evans, Francesca Aroldi et al.|Annals of Oncology|2020Cited by 1
475P A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302)Jordan Berlin, Sarah P. Blagden, Mary Linton B. Peters et al.|Annals of Oncology|2021Cited by 1